steroplast healthcare limited Company Information
Company Number
00504340
Next Accounts
Dec 2024
Industry
Non-specialised wholesale trade
Other manufacturing n.e.c.
Shareholders
adam carter brown
mark doncaster brown
Group Structure
View All
Contact
Registered Address
alpha point, bradnor road, manchester, M22 4TE
Website
www.steroplast.co.uksteroplast healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of STEROPLAST HEALTHCARE LIMITED at £3.5m based on a Turnover of £5.3m and 0.66x industry multiple (adjusted for size and gross margin).
steroplast healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of STEROPLAST HEALTHCARE LIMITED at £0 based on an EBITDA of £-1m and a 5.25x industry multiple (adjusted for size and gross margin).
steroplast healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of STEROPLAST HEALTHCARE LIMITED at £3.6m based on Net Assets of £2.1m and 1.72x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Steroplast Healthcare Limited Overview
Steroplast Healthcare Limited is a live company located in manchester, M22 4TE with a Companies House number of 00504340. It operates in the other manufacturing n.e.c. sector, SIC Code 32990. Founded in March 1952, it's largest shareholder is adam carter brown with a 95.2% stake. Steroplast Healthcare Limited is a mature, mid sized company, Pomanda has estimated its turnover at £5.3m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Steroplast Healthcare Limited Health Check
Pomanda's financial health check has awarded Steroplast Healthcare Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
7 Weak
Size
annual sales of £5.3m, make it smaller than the average company (£13.5m)
- Steroplast Healthcare Limited
£13.5m - Industry AVG
Growth
3 year (CAGR) sales growth of -1%, show it is growing at a slower rate (4.7%)
- Steroplast Healthcare Limited
4.7% - Industry AVG
Production
with a gross margin of 28.6%, this company has a comparable cost of product (28.6%)
- Steroplast Healthcare Limited
28.6% - Industry AVG
Profitability
an operating margin of -20.3% make it less profitable than the average company (5.9%)
- Steroplast Healthcare Limited
5.9% - Industry AVG
Employees
with 31 employees, this is below the industry average (53)
31 - Steroplast Healthcare Limited
53 - Industry AVG
Pay Structure
on an average salary of £40.8k, the company has an equivalent pay structure (£40.8k)
- Steroplast Healthcare Limited
£40.8k - Industry AVG
Efficiency
resulting in sales per employee of £171.5k, this is less efficient (£263.8k)
- Steroplast Healthcare Limited
£263.8k - Industry AVG
Debtor Days
it gets paid by customers after 57 days, this is near the average (56 days)
- Steroplast Healthcare Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 33 days, this is quicker than average (40 days)
- Steroplast Healthcare Limited
40 days - Industry AVG
Stock Days
it holds stock equivalent to 129 days, this is more than average (73 days)
- Steroplast Healthcare Limited
73 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 26 weeks, this is more cash available to meet short term requirements (14 weeks)
26 weeks - Steroplast Healthcare Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 23.7%, this is a lower level of debt than the average (48.5%)
23.7% - Steroplast Healthcare Limited
48.5% - Industry AVG
STEROPLAST HEALTHCARE LIMITED financials
Steroplast Healthcare Limited's latest turnover from March 2023 is estimated at £5.3 million and the company has net assets of £2.1 million. According to their latest financial statements, Steroplast Healthcare Limited has 31 employees and maintains cash reserves of £296.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 31 | 30 | 31 | 30 | 29 | 31 | 31 | 28 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 206,042 | 873,555 | 874,286 | 936,588 | 996,954 | 986,815 | 958,022 | 962,726 | 1,000,932 | 973,322 | 1,000,660 | 926,605 | 898,401 | 928,460 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 402,204 | 401,630 | 401,630 | 400,559 | 396,690 | 388,045 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 206,042 | 1,275,759 | 1,275,916 | 1,338,218 | 1,397,513 | 1,383,505 | 1,346,067 | 962,726 | 1,000,932 | 973,322 | 1,000,660 | 926,605 | 898,401 | 928,460 |
Stock & work in progress | 1,342,713 | 909,233 | 981,592 | 899,509 | 1,109,242 | 1,216,393 | 1,063,578 | 1,116,543 | 1,026,647 | 981,294 | 1,143,491 | 992,853 | 869,788 | 841,958 |
Trade Debtors | 833,786 | 1,027,291 | 685,350 | 1,022,939 | 936,543 | 891,536 | 969,062 | 906,956 | 1,199,118 | 1,096,027 | 884,845 | 810,548 | 751,121 | 669,693 |
Group Debtors | 2,792 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 24,096 | 67,359 | 139,814 | 199,768 | 131,264 | 115,851 | 163,496 | 210,962 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 296,208 | 535,065 | 821,224 | 634,047 | 483,775 | 105,206 | 358,592 | 249,023 | 77,987 | 215,298 | 74 | 307,681 | 251,191 | 221,411 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 2,499,595 | 2,538,948 | 2,627,980 | 2,756,263 | 2,660,824 | 2,328,986 | 2,554,728 | 2,483,484 | 2,303,752 | 2,292,619 | 2,028,410 | 2,111,082 | 1,872,100 | 1,733,062 |
total assets | 2,705,637 | 3,814,707 | 3,903,896 | 4,094,481 | 4,058,337 | 3,712,491 | 3,900,795 | 3,446,210 | 3,304,684 | 3,265,941 | 3,029,070 | 3,037,687 | 2,770,501 | 2,661,522 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 18,966 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 27,021 | 21,962 | 19,903 | 0 | 18,663 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 351,810 | 335,494 | 284,671 | 550,658 | 650,590 | 366,188 | 657,858 | 549,114 | 631,021 | 746,054 | 627,944 | 664,916 | 660,732 | 721,773 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 9,981 | 8,050 | 1,026 | 6,150 | 7,268 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 214,763 | 318,772 | 516,074 | 361,396 | 206,818 | 265,084 | 161,766 | 210,907 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 576,554 | 662,316 | 828,792 | 940,166 | 884,579 | 650,238 | 838,287 | 760,021 | 631,021 | 746,054 | 627,944 | 664,916 | 660,732 | 721,773 |
loans | 0 | 0 | 101,089 | 267,577 | 289,849 | 310,475 | 329,779 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 45,681 | 10,733 | 0 | 1,025 | 6,057 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,025 | 9,074 | 32,106 | 32,554 | 60,530 | 121,515 |
provisions | 17,672 | 12,258 | 16,212 | 23,479 | 23,479 | 33,638 | 28,059 | 21,177 | 21,177 | 22,576 | 28,097 | 31,568 | 10,347 | 9,546 |
total long term liabilities | 63,353 | 22,991 | 117,301 | 292,081 | 319,385 | 344,113 | 357,838 | 21,177 | 25,202 | 31,650 | 60,203 | 64,122 | 70,877 | 131,061 |
total liabilities | 639,907 | 685,307 | 946,093 | 1,232,247 | 1,203,964 | 994,351 | 1,196,125 | 781,198 | 656,223 | 777,704 | 688,147 | 729,038 | 731,609 | 852,834 |
net assets | 2,065,730 | 3,129,400 | 2,957,803 | 2,862,234 | 2,854,373 | 2,718,140 | 2,704,670 | 2,665,012 | 2,648,461 | 2,488,237 | 2,340,923 | 2,308,649 | 2,038,892 | 1,808,688 |
total shareholders funds | 2,065,730 | 3,129,400 | 2,957,803 | 2,862,234 | 2,854,373 | 2,718,140 | 2,704,670 | 2,665,012 | 2,648,461 | 2,488,237 | 2,340,923 | 2,308,649 | 2,038,892 | 1,808,688 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 58,831 | 48,785 | 60,284 | 85,159 | 32,453 | 3,160 | 69,929 | 66,387 | 65,733 | 68,020 | 53,443 | 68,252 | 74,272 | |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Tax | ||||||||||||||
Stock | 433,480 | -72,359 | 82,083 | -209,733 | -107,151 | 152,815 | -52,965 | 89,896 | 45,353 | -162,197 | 150,638 | 123,065 | 27,830 | 841,958 |
Debtors | -233,976 | 269,486 | -397,543 | 154,900 | 60,420 | -125,171 | 14,640 | -81,200 | 103,091 | 211,182 | 74,297 | 59,427 | 81,428 | 669,693 |
Creditors | 16,316 | 50,823 | -265,987 | -99,932 | 284,402 | -291,670 | 108,744 | -81,907 | -115,033 | 118,110 | -36,972 | 4,184 | -61,041 | 721,773 |
Accruals and Deferred Income | -104,009 | -197,302 | 154,678 | 154,578 | -58,266 | 103,318 | -49,141 | 210,907 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 5,414 | -3,954 | -7,267 | 0 | -10,159 | 5,579 | 6,882 | 0 | -1,399 | -5,521 | -3,471 | 21,221 | 801 | 9,546 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | -402,204 | 574 | 0 | 1,071 | 3,869 | 8,645 | 388,045 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | -27,021 | 5,059 | 2,059 | 19,903 | -18,663 | 18,663 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | -101,089 | -166,488 | -22,272 | -20,626 | -19,304 | 329,779 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 36,879 | 17,757 | -6,149 | -6,150 | 13,325 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,025 | -5,049 | -23,032 | -448 | -27,976 | -60,985 | 121,515 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -238,857 | -286,159 | 187,177 | 150,272 | 378,569 | -253,386 | 109,569 | 171,036 | -137,311 | 215,224 | -307,607 | 56,490 | 29,780 | 221,411 |
overdraft | 0 | 0 | 0 | 0 | -18,966 | 18,966 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -238,857 | -286,159 | 187,177 | 150,272 | 397,535 | -272,352 | 109,569 | 171,036 | -137,311 | 215,224 | -307,607 | 56,490 | 29,780 | 221,411 |
steroplast healthcare limited Credit Report and Business Information
Steroplast Healthcare Limited Competitor Analysis
Perform a competitor analysis for steroplast healthcare limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in M22 area or any other competitors across 12 key performance metrics.
steroplast healthcare limited Ownership
STEROPLAST HEALTHCARE LIMITED group structure
Steroplast Healthcare Limited has no subsidiary companies.
Ultimate parent company
STEROPLAST HEALTHCARE LIMITED
00504340
steroplast healthcare limited directors
Steroplast Healthcare Limited currently has 2 directors. The longest serving directors include Mr Adam Brown (Jul 1997) and Mr Mohammed Ramzan (Nov 2002).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Adam Brown | United Kingdom | 61 years | Jul 1997 | - | Director |
Mr Mohammed Ramzan | 53 years | Nov 2002 | - | Director |
P&L
March 2023turnover
5.3m
0%
operating profit
-1.1m
0%
gross margin
28.6%
-0.51%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
2.1m
-0.34%
total assets
2.7m
-0.29%
cash
296.2k
-0.45%
net assets
Total assets minus all liabilities
steroplast healthcare limited company details
company number
00504340
Type
Private limited with Share Capital
industry
46900 - Non-specialised wholesale trade
32990 - Other manufacturing n.e.c.
incorporation date
March 1952
age
72
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2023
previous names
steroplast ltd (March 2009)
adhesive fabrics (manchester) limited (May 1988)
accountant
-
auditor
-
address
alpha point, bradnor road, manchester, M22 4TE
Bank
-
Legal Advisor
-
steroplast healthcare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 9 charges/mortgages relating to steroplast healthcare limited. Currently there are 2 open charges and 7 have been satisfied in the past.
steroplast healthcare limited Companies House Filings - See Documents
date | description | view/download |
---|